Invirsa (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- June 14, 2023
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $7,700,000
Company Info
- Founders
- Dr. Robert Shalwitz
- Company Description
- Invirsa develops a molecule that promotes ocular DNA repair and the innate immune response to infection and injury.
- Market
- Ocular conditions
- Location
- Columbus, Ohio, USA
- Coinvestors
- CincyTech, JobsOhio, JumpStart Ventures, Rev1 Ventures